Responses
Abstract
Posters October 4
LONG-TERM RESULTS AND PROGNOSTIC ANALYSES IN RECURRENT/REFRACTORY EPITHELIAL OVARIAN CANCER (RREOC) TREATED BY HIGH-DOSE CHEMOTHERAPY (HDC) WITH AUTOLOGOUS STEM CELL SUPPORT (ASCS)
Compose a Response to This Article
Other responses
No responses have been published for this article.